The broad long-term goals of this project are to better understand the kinetics of transport of active and excipient microbicide agents through vaginal/cervical tissue, to evaluate the effects of excipients on components of the genital tract as well as STD pathogens including HIV, and to incorporate knowledge of these factors into formulation strategies for octyl glycerol with or without peptides. Remedies have been developed which show promise as active agents against STDs as microbicides. However, very little basic information has been generated regarding the transport kinetics in vaginal and cervical tissues for active and excipient agents which may be used in topical microbicide formulations. Therefore, the specific aims of this project are to: 1) define the transport kinetics of hydrophilic and lipophilic low molecular weight compounds through vaginal and cervical tissue using a Franz cell diffusion model, 2) assess the impact of formulation excipients on transport of active microbicide agents through vaginal and cervical tissue, 3) evaluate the in vitro activity of formulation components on Neisseria gonorrhoeae, Chlamydia trachomatis, Lactobacillus crispatus, Trichomonas vaginalis and other competents of the genital tract in collaboration with the Cores 4) develop a formulation for octyl glycerol in collaboration with Dr. Isaacs as proposed in the second Project, 5) assess the physical and chemical properties of the developed octyl glycerol formulation using traditional pharmaceutical dosage form evaluation techniques and 6) evaluate the effectiveness of individual formulation components and formulated products against HIV in a tissue model system in collaboration with the third project and against Chlamydia trachomatis in the pig-tailed macaque in collaboration with the first Project.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI039061-06
Application #
6352617
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2000-09-15
Project End
2001-08-31
Budget Start
Budget End
Support Year
6
Fiscal Year
2000
Total Cost
$58,334
Indirect Cost
Name
Magee-Women's Hospital of Upmc
Department
Type
DUNS #
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Moncla, Bernard J; Guevara, Peter W; Wallace, James A et al. (2012) The inhibitory activity of typified propolis against Enterococcus species. Z Naturforsch C 67:249-56
Wang, Lin; Sassi, Alexandra Beumer; Patton, Dorothy et al. (2012) Development of a liposome microbicide formulation for vaginal delivery of octylglycerol for HIV prevention. Drug Dev Ind Pharm 38:995-1007
Moncla, B J; Pryke, K; Rohan, L C et al. (2012) Testing of viscous anti-HIV microbicides using Lactobacillus. J Microbiol Methods 88:292-6
Moncla, Bernard J; Pryke, Kara; Rohan, Lisa Cencia et al. (2011) Degradation of naturally occurring and engineered antimicrobial peptides by proteases. Adv Biosci Biotechnol 2:404-408
Skinner, M C; Stamm, W E; Lampe, M L (2009) Chlamydia trachomatis laboratory strains versus recent clinical isolates: implications for routine microbicide testing. Antimicrob Agents Chemother 53:1482-9
Patton, Dorothy L; Sweeney, Yvonne T Cosgrove; Paul, Kathleen J (2009) A summary of preclinical topical microbicide rectal safety and efficacy evaluations in a pigtailed macaque model. Sex Transm Dis 36:350-6
Sassi, Alexandra B; Isaacs, Charles E; Moncla, Bernard J et al. (2008) Effects of physiological fluids on physical-chemical characteristics and activity of topical vaginal microbicide products. J Pharm Sci 97:3123-39
Moncla, B J; Pryke, K; Isaacs, Charles E (2008) Killing of Neisseria gonorrhoeae, Streptococcus agalactiae (group B streptococcus), Haemophilus ducreyi, and vaginal Lactobacillus by 3-O-octyl-sn-glycerol. Antimicrob Agents Chemother 52:1577-9
Deslouches, Berthony; Gonzalez, Ivan A; DeAlmeida, Dilhari et al. (2007) De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia. J Antimicrob Chemother 60:669-72
Patton, D L; Cosgrove Sweeney, Y T; McCarthy, T D et al. (2006) Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model. Antimicrob Agents Chemother 50:1696-700

Showing the most recent 10 out of 42 publications